{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:46:37Z","timestamp":1776602797796,"version":"3.51.2"},"reference-count":136,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Novel coronavirus SARS-CoV-2 has resulted in a global pandemic with worldwide 6-digit infection rates and thousands of death tolls daily. Enormous efforts are undertaken to achieve high coverage of immunization to reach herd immunity in order to stop the spread of SARS-CoV-2 infection. Several SARS-CoV-2 vaccines based on mRNA, viral vectors, or inactivated SARS-CoV-2 virus have been approved and are being applied worldwide. However, the recent increased numbers of normally very rare types of thromboses associated with thrombocytopenia have been reported, particularly in the context of the adenoviral vector vaccine ChAdOx1 nCoV-19 from Astra Zeneca. The statistical prevalence of these side effects seems to correlate with this particular vaccine type, i.e., adenoviral vector-based vaccines, but the exact molecular mechanisms are still not clear. The present review summarizes current data and hypotheses for molecular and cellular mechanisms into one integrated hypothesis indicating that coagulopathies, including thromboses, thrombocytopenia, and other related side effects, are correlated to an interplay of the two components in the vaccine, i.e., the spike antigen and the adenoviral vector, with the innate and immune systems, which under certain circumstances can imitate the picture of a limited COVID-19 pathological picture.<\/jats:p>","DOI":"10.3390\/ijms221910791","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T16:23:58Z","timestamp":1633623838000},"page":"10791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-6705","authenticated-orcid":false,"given":"Ralf","family":"Kircheis","sequence":"first","affiliation":[{"name":"Syntacoll GmbH, 93342 Saal an der Donau, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, random-ised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Schulz, J.B., Berlit, P., Diener, H.C., Gerloff, C., Greinacher, A., Klein, C., Petzold, G., Poli, S., Piccininni, M., and Kurth, T. (2021). COVID-19 vaccine-associated cerebral venous thrombosis in Germany: A descriptive study. medRxiv.","DOI":"10.1101\/2021.04.30.21256383"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"See, I., Su, J.R., Lale, A., Woo, E.J., Guh, A.Y., Shimabukuro, T.T., Streiff, M.B., Rao, A.K., Wheeler, A.P., and Beavers, S.F. (2021). US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA, 325.","DOI":"10.1001\/jama.2021.7517"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Abdelrahman, Z., Li, M., and Wang, X. (2020). Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.552909"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pollock, A.M., and Lancaster, J. (2020). Asymptomatic transmission of covid-19. BMJ, 371.","DOI":"10.1136\/bmj.m4851"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/all.14462","article-title":"Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives\u2014A report of the European Academy of Allergy and Clinical Immunology (EAACI)","volume":"75","author":"Sokolowska","year":"2020","journal-title":"Allergy"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis","volume":"81","author":"Zheng","year":"2020","journal-title":"J. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3947\/ic.2020.52.2.154","article-title":"Age-Related Morbidity and Mortality among Patients with COVID-19","volume":"52","author":"Kang","year":"2020","journal-title":"Infect. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000512592","article-title":"Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis","volume":"64","author":"Biswas","year":"2021","journal-title":"Intervirology"},{"key":"ref_24","first-page":"140","article-title":"Age-specific mortality and immunity patterns of SARS-CoV-2","volume":"590","author":"Wang","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"P1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary most-mortem findings in a large series of COVID-19 cases from Northern Italy","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: Immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: Risk for cytokine targeting in chronic inflammatory diseases?","volume":"20","author":"Schett","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.stem.2020.09.013","article-title":"SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response","volume":"27","author":"Huang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Neufeldt, C.J., Cerikan, B., Cortese, M., Frankish, J., Lee, J.Y., Plociennikowska, A., Heigwer, F., Joecks, S., Burkart, S.S., and Zander, D.Y. (2020). SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB. bioRxiv.","DOI":"10.1101\/2020.07.21.212639"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hojyo, S., Uchida, M., Tanaka, K., Hasebe, R., Tanaka, Y., Murakami, M., and Hirano, T. (2020). How COVID-19 induces cytokine storm with high mortality. Inflamm. Regen., 40.","DOI":"10.1186\/s41232-020-00146-3"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2020.04.003","article-title":"COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome","volume":"52","author":"Hirano","year":"2020","journal-title":"Immunity"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hong, K.S., Ahn, J.H., Jang, J.G., Lee, J.H., Kim, H.N., Kim, D., and Lee, W. (2020). GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct. Target. Ther., 5.","DOI":"10.1038\/s41392-020-00391-5"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"McAleavy, M., Zhang, Q., Xu, J., Pan, L., Wakai, M., Ehmann, P.J., Wipperman, M.F., Shavlakadze, T., Hamon, S.C., and Boyapati, A. (2021). Activin A correlates with the worst outcomes in COVID-19 patients, and can be induced by cytokines via the IKK\/NF-kappa B pathway. bioRxiv.","DOI":"10.1101\/2021.02.04.429815"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","article-title":"The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients","volume":"29","author":"Hariharan","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kircheis, R., Haasbach, E., Lueftenegger, D., Heyken, W.T., Ocker, M., and Planz, O. (2020). NF-\u03baB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.598444"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4049\/jimmunol.2000644","article-title":"COVID-19: Complement, Coagulation, and Collateral Damage","volume":"205","author":"Lo","year":"2020","journal-title":"J. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Polycarpou, A., Howard, M., Farrar, C.A., Greenlaw, R., Fanelli, G., Wallis, R., Klavinskis, L.S., and Sacks, S. (2020). Rationale for targeting complement in COVID-19. EMBO Mol. Med., 12.","DOI":"10.15252\/emmm.202012642"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2020.06.027","article-title":"Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review","volume":"194","author":"Bellander","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Bas\u00edlio, J., Petzelbauer, P., and Assinger, A. (2019). Cell Type-Specific Roles of NF-\u03baB Linking Inflammation and Thrombosis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00085"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"McCarthy, C.G., Wilczynski, S., Wenceslau, C.F., and Webb, R.C. (2021). A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. Vasc. Pharmacol., 137.","DOI":"10.1016\/j.vph.2020.106826"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., St\u00fcrzl, M., Staats, L., Mahajan, A., and Schauer, C. (2020). Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine, 58.","DOI":"10.1016\/j.ebiom.2020.102925"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Kvietys, P.R., Fakhoury, H.M.A., Kadan, S., Yaqinuddin, A., Al-Mutairy, E., and Al-Kattan, K. (2021). COVID-19: Lung-Centric Immunothrombosis. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.679878"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gando, S., and Wada, T. (2021). Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights from Thrombosis and Hemostasis. Shock.","DOI":"10.1097\/SHK.0000000000001825"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"De Buhr, N., and von K\u00f6ckritz-Blickwede, M. (2021). The Balance of Neutrophil Extracellular Trap Formation and Nuclease Degradation: An Unknown Role of Bacterial Coinfections in COVID-19 Patients?. mBio, 12.","DOI":"10.1128\/mBio.03304-20"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endotheliopathy: Crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Zuo, Y., Estes, S.K., Ali, R.A., Gandhi, A.A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J.A., and Zuo, M. (2020). Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Oxley, T.J., Mocco, J., Majidi, S., Kellner, C.P., Shoirah, H., Singh, I.P., De Leacy, R.A., Shigematsu, T., Ladner, T.R., and Yaeger, K.A. (2020). Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N. Engl. J. Med., 382.","DOI":"10.1056\/NEJMc2009787"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","article-title":"Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations","volume":"4","author":"Diorio","year":"2020","journal-title":"Blood Adv."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of Thrombotic Microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic Microangiopathy and the Kidney","volume":"13","author":"Brocklebank","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: A general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"Can. Med Assoc. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Hunter, P.R. (2021). Thrombosis after covid-19 vaccination. BMJ, 373.","DOI":"10.1136\/bmj.n958"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2020.10.008","article-title":"COVID-19\u2013associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome\u2014the superantigen hypothesis","volume":"147","author":"Rivas","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kouo, T., and Chaisawangwong, W. (2021). SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children (MIS-C). J. Clin. Investig., 131.","DOI":"10.1172\/JCI149327"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Scaglioni, V., and Soriano, E.R. (2020). Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis. Scand. J. Immunol., 92.","DOI":"10.1111\/sji.12944"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/a-1404-6763","article-title":"Erste F\u00e4lle des Multisystem Inflammatory Syndrome nach SARS-CoV-2-Infektion bei jungen Erwachsenen in Deutschland [First Cases of Multisystem Inflammatory Syndrome following SARS-CoV-2 infection in Adults in Germany]","volume":"146","author":"Rieper","year":"2021","journal-title":"Dtsch. Med. Wochenschr."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Iba, T., Umemura, Y., Wada, H., and Levy, H. (2021). The Roles of Coagulation Disorder and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment. Arch. Med Res., 31.","DOI":"10.1016\/j.arcmed.2021.07.003"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/j.1538-7836.2003.00498.x","article-title":"Superantigens from Staphylococcus aureus induce procoagulant activity and monocyte tissue factor expression in whole blood and mononuclear cells via IL-1beta","volume":"1","author":"Mattsson","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12026-014-8538-8","article-title":"Staphylococcal toxic shock syndrome: Superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression","volume":"59","author":"Kulhankova","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.4049\/jimmunol.150.12.5604","article-title":"Microbial superantigens induce NF-kappa B in the human monocytic cell line THP-1","volume":"150","author":"Trede","year":"1993","journal-title":"J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0212736","article-title":"Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model","volume":"109","author":"Zollner","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08923970701692577","article-title":"The Potency of Anti-Oxidants in Attenuating Superantigen-Induced Proinflammatory Cytokines Correlates with Inactivation of NF-\u03baB","volume":"30","author":"Krakauer","year":"2008","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19771","DOI":"10.1074\/jbc.RA118.003668","article-title":"Enhanced interaction between SEC2 mutant and TCR V\u03b2 induces MHC II\u2013independent activation of T cells via PKC\u03b8\/NF-\u03baB and IL-2R\/STAT5 signaling pathways","volume":"293","author":"Fu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.it.2013.02.002","article-title":"A new look at T cell receptor signaling to nuclear factor-\u03baB","volume":"34","author":"Paul","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Khan, S., Shafiei, M.S., Longoria, C., Schoggins, J., Savani, R.C., and Zaki, H. (2021). SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway. bioRxiv.","DOI":"10.1101\/2021.03.16.435700"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Patra, T., Meyer, K., Geerling, L., Isbell, T.S., Hoft, D.F., Brien, J., Pinto, A.K., Ray, R.B., and Ray, R. (2020). SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1009128"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Hsu, A.C.-Y., Wang, G., Reid, A.T., Veerati, P.C., Pathinayake, P.S., Daly, K., Mayall, J.R., Hansbro, P.M., Horvat, J.C., and Wang, F. (2020). SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors in vitro. bioRxiv.","DOI":"10.1101\/2020.09.30.317818"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s10753-021-01464-5","article-title":"Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone","volume":"44","author":"Olajide","year":"2021","journal-title":"Inflamm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jmcb\/mjaa067","article-title":"SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity","volume":"12","author":"Petruk","year":"2021","journal-title":"J. Mol. Cell Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","article-title":"Up-regulation of IL-6 and TNF-\u03b1 induced by SARS-coronavirus spike protein in murine macrophages via NF-\u03baB pathway","volume":"128","author":"Wang","year":"2007","journal-title":"Virus Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"L477","DOI":"10.1152\/ajplung.00223.2021","article-title":"The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in \u039a18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells","volume":"321","author":"Biancatelli","year":"2021","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"18127","DOI":"10.1074\/jbc.M310438200","article-title":"Tumor Necrosis Factor \u03b1 Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor \u03baB Site","volume":"279","author":"Hou","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1067\/mtc.2003.99","article-title":"Nuclear factor \u03baB mediates a procoagulant response in monocytes during extracorporeal circulation","volume":"125","author":"Morgan","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2006.02046.x","article-title":"The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-?B activation","volume":"4","author":"Kastl","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kojok, K., El-Kadiry, A.E.-H., and Merhi, Y. (2019). Role of NF-\u03baB in Platelet Function. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174185"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Grant, A.H., Estrada, A.I., Ayala-Marin, Y.M., Alvidrez-Camacho, A.Y., Rodriguez, G., Robles-Escajeda, E., Cadena-Medina, D.A., Rodriguez, A.C., and Kirken, R.A. (2021). The Many Faces of JAKs and STATs Within the COVID-19 Storm. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.690477"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jafarzadeh, A., Nemati, M., and Jafarzadeh, S. (2021). Contribution of STAT3 to the pathogenesis of COVID-19. Microb. Pathog., 154.","DOI":"10.1016\/j.micpath.2021.104836"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/s41418-020-00633-7","article-title":"An aberrant STAT pathway is central to COVID-19","volume":"27","author":"Matsuyama","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","article-title":"Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level","volume":"19","author":"Thomas","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., and Zhou, Y. (2021). The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct. Target. Ther., 6.","DOI":"10.1038\/s41392-021-00679-0"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, J., Jie, X., Liang, X., Chen, Z., Xie, P., Pan, X., Zhou, B., and Li, J. (2020). Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-\u03baB and MAPKs signalings. BMC Complement. Med. Ther., 20.","DOI":"10.1186\/s12906-020-02918-3"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Leitzke, M., Stefanovic, D., Meyer, J.-J., Schimpf, S., and Sch\u00f6nknecht, P. (2020). Autonomic balance determines the severity of COVID-19 courses. Bioelectron. Med., 6.","DOI":"10.1186\/s42234-020-00058-0"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Cai, Z., Greene, M.I., Zhu, Z., and Zhang, H. (2020). Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19. Antibodies, 9.","DOI":"10.3390\/antib9040052"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Nevzorova, T.A., Mordakhanova, E.R., Daminova, A.G., Ponomareva, A.A., Andrianova, I.A., Le Minh, G., Rauova, L., Litvinov, R.I., and Weisel, J.W. (2019). Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death. Cell Death Discov., 5.","DOI":"10.1038\/s41420-019-0188-0"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jca.20109","article-title":"Heparin-induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly\/disassembly","volume":"22","author":"Cines","year":"2007","journal-title":"J. Clin. Apher."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1073\/pnas.85.24.9396","article-title":"Charge configurations in viral proteins","volume":"85","author":"Karlin","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1002\/jssc.201600829","article-title":"Manipulating adenoviral vector ion-exchange chromatography: Hexon versus fiber","volume":"39","author":"Majhen","year":"2016","journal-title":"J. Sep. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1074\/jbc.272.10.6479","article-title":"Complexes of Adenovirus with Polycationic Polymers and Cationic Lipids Increase the Efficiency of Gene Transfer in Vitro and in Vivo","volume":"272","author":"Fasbender","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.gt.3300349","article-title":"Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro","volume":"4","author":"Arcasoy","year":"1997","journal-title":"Gene Ther."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Baker, A.T., Boyd, R.J., Sarkar, D., Vant, J.W., Teijeira-Crespo, A., Truong, C.D., Bates, E.A., Wilson, E.A., Chan, C.K., and Lipka-Lloyd, M. (2021). The Structure of ChAdOx1\/AZD-1222 Reveals Interactions with CAR and PF4 with Implications for Vaccine-induced Immune Thrombotic Thrombocytopenia. bioRxiv.","DOI":"10.1101\/2021.05.19.444882"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Greinacher, A., Selleng, K., Mayerle, J., Palankar, R., Wesche, J., Reiche, S., Aebischer, A., E Warkentin, T., Muenchhoff, M., and Hellmuth, J.C. (2021). Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. Blood.","DOI":"10.1182\/blood.2021012938"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Greinacher, A., Selleng, K., Wesche, J., Handtke, S., Palankar, R., Aurich, K., Lalk, M., Methling, K., V\u00f6lker, U., and Hentsch-ker, C. (2021). Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT). Res. Sq.","DOI":"10.21203\/rs.3.rs-440461\/v1"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shi, C., Yang, L., Braun, A., and Anders, H.-J. (2020). Extracellular DNA\u2014A Danger Signal Triggering Immunothrombosis. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.568513"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Fox, J.M., Kausar, F., Day, A., Osborne, M., Hussain, K., Mueller, A., Lin, J., Tsuchiya, T., Kanegasaki, S., and Pease, J.E. (2018). CXCL4\/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-27710-9"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis","volume":"125","author":"Kowalska","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Almuqrin, A., Davidson, A.D., Williamson, M.K., Lewis, P.A., Heesom, K.J., Morris, S., Gilbert, S.C., and Matthews, D.A. (2021). SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription. Genome Med., 13.","DOI":"10.1186\/s13073-021-00859-1"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Coughlan, L. (2020). Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00909"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/JVI.02819-06","article-title":"Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver","volume":"81","author":"Stone","year":"2007","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: The role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance","volume":"109","author":"Othman","year":"2006","journal-title":"Blood"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/10430349950018364","article-title":"Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in Vivo","volume":"10","author":"Muruve","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/sj.gt.3301533","article-title":"Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector","volume":"8","author":"Melotti","year":"2001","journal-title":"Gene Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0042-6822(02)00078-8","article-title":"MAP kinases and NF-\u03baB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection","volume":"307","author":"Tamanini","year":"2003","journal-title":"Virology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.1128\/JVI.00721-06","article-title":"Interaction of Adenovirus Type 5 Fiber with the Coxsackievirus and Adenovirus Receptor Activates Inflammatory Response in Human Respiratory Cells","volume":"80","author":"Tamanini","year":"2006","journal-title":"J. Virol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.76.1.127-135.2002","article-title":"Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response","volume":"76","author":"Lengagne","year":"2002","journal-title":"J. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1128\/JVI.74.20.9617-9628.2000","article-title":"Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-\u03baB-Dependent Pathway","volume":"74","author":"Morelli","year":"2000","journal-title":"J. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","article-title":"Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?","volume":"60","author":"Talotta","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Goldman, M., and Hermans, C. (2021). Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity. PLoS Med., 18.","DOI":"10.1371\/journal.pmed.1003648"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1128\/JVI.76.6.2899-2911.2002","article-title":"Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product","volume":"76","author":"Mercier","year":"2002","journal-title":"J. Virol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ. Res."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Nuovo, G.J., Magro, C., Shaffer, T., Awad, H., Suster, D., Mikhail, S., He, B., Michaille, J.-J., Liechty, B., and Tili, E. (2021). Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein. Ann. Diagn. Pathol., 51.","DOI":"10.1016\/j.anndiagpath.2020.151682"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Liu, L., Chopra, P., Li, X., Wolfert, M.A., Tompkins, S.M., and Boons, G.J. (2020). Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2. bioRxiv.","DOI":"10.1101\/2020.05.10.087288"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Kowarz, E., Krutzke, L., Reis, J., Bracharz, S., Kochanek, S., and Marschalek, R. (2021). \u201cVaccine-Induced Covid-19 Mimicry\u201d Syndrome: Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines. Preprint Res. Sq.","DOI":"10.21203\/rs.3.rs-558954\/v1"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Machitani, M., Sakurai, F., Wakabayashi, K., Nakatani, K., Shimizu, K., Tachibana, M., and Mizuguchi, H. (2016). NF-\u03baB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector. Sci. Rep., 6.","DOI":"10.1038\/srep19922"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Krutzke, L., Roesler, R., Wiese, S., and Kochanek, S. (2021). Process-related impurities in the ChAdOx1 nCov-19 vaccine. Preprint Res. Sq.","DOI":"10.21203\/rs.3.rs-477964\/v1"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000207194","article-title":"TRIF, and TRIF-Interacting TLRs Differentially Modulate Several Adenovirus Vector-Induced Immune Responses","volume":"1","author":"Appledorn","year":"2009","journal-title":"J. Innate Immun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/MCB.22.16.5912-5922.2002","article-title":"\u03b15\u03b21 Integrin Activates an NF-\u03baB-Dependent Program of Gene Expression Important for Angiogenesis and Inflammation","volume":"22","author":"Klein","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.200410073","article-title":"The subendothelial extracellular matrix modulates NF-kappaB activation by flow: A potential role in atherosclerosis","volume":"169","author":"Orr","year":"2005","journal-title":"J. Cell Biol."},{"key":"ref_133","first-page":"479","article-title":"COVID vaccines and blood clots: What researchers know so far","volume":"596","author":"Ledford","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.gt.3300576","article-title":"High adenoviral loads stimulate NF\u03baB-dependent gene expression in human vascular smooth muscle cells","volume":"5","author":"Clesham","year":"1998","journal-title":"Gene Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/01.ATV.0000200083.95349.9e","article-title":"Effect of Vectors on Human Endothelial Cell Signal Transduction","volume":"26","author":"Tan","year":"2006","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_136","first-page":"1422","article-title":"Adenovirus-mediated overexpression of novel mutated IkappaBalpha inhibits nuclear factor kappaB activation in endothelial cells","volume":"118","author":"Zhou","year":"2005","journal-title":"Chin. Med. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:09:45Z","timestamp":1760166585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":136,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms221910791"],"URL":"https:\/\/doi.org\/10.3390\/ijms221910791","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]}}}